FERRACIN, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 10.751
AS - Asia 4.814
EU - Europa 2.720
SA - Sud America 701
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 103
OC - Oceania 17
Totale 19.299
Nazione #
US - Stati Uniti d'America 10.515
SG - Singapore 1.884
CN - Cina 1.156
BR - Brasile 533
VN - Vietnam 518
DE - Germania 509
IT - Italia 493
UA - Ucraina 390
HK - Hong Kong 376
GB - Regno Unito 298
TR - Turchia 298
FI - Finlandia 238
PL - Polonia 153
FR - Francia 141
SE - Svezia 136
BD - Bangladesh 118
CA - Canada 117
RU - Federazione Russa 106
JP - Giappone 101
IN - India 87
MX - Messico 85
ID - Indonesia 72
AR - Argentina 67
NL - Olanda 62
ZA - Sudafrica 35
ES - Italia 33
IQ - Iraq 33
AT - Austria 29
BE - Belgio 28
RO - Romania 27
CO - Colombia 25
EC - Ecuador 20
LT - Lituania 20
PK - Pakistan 19
SA - Arabia Saudita 19
CL - Cile 17
PH - Filippine 17
UZ - Uzbekistan 17
AU - Australia 16
TN - Tunisia 16
CZ - Repubblica Ceca 14
JM - Giamaica 13
VE - Venezuela 13
EG - Egitto 12
KR - Corea 12
MY - Malesia 12
IR - Iran 11
CH - Svizzera 9
DZ - Algeria 8
KE - Kenya 8
MA - Marocco 8
NP - Nepal 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
JO - Giordania 6
LB - Libano 6
OM - Oman 6
PE - Perù 6
PY - Paraguay 6
TH - Thailandia 6
BO - Bolivia 5
CR - Costa Rica 5
IE - Irlanda 5
AZ - Azerbaigian 4
ET - Etiopia 4
GR - Grecia 4
GT - Guatemala 4
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
LC - Santa Lucia 2
LY - Libia 2
MU - Mauritius 2
PA - Panama 2
SR - Suriname 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
GN - Guinea 1
KH - Cambogia 1
Totale 19.102
Città #
Ashburn 1.116
Singapore 1.111
Fairfield 1.070
Woodbridge 983
San Jose 712
Houston 614
Chandler 461
Jacksonville 437
Seattle 430
Santa Clara 425
Ann Arbor 421
Beijing 391
Hong Kong 364
Wilmington 348
Cambridge 332
Council Bluffs 241
Izmir 184
Munich 181
Los Angeles 174
Ho Chi Minh City 168
Warsaw 148
New York 139
Dallas 135
Nanjing 126
Ferrara 117
Hanoi 113
Princeton 100
Helsinki 95
Tokyo 91
San Diego 89
Boardman 81
Lauterbourg 78
Milan 69
São Paulo 65
Shanghai 58
Jakarta 55
Orem 54
Mexico City 49
London 48
Chicago 47
Turku 46
Nanchang 42
Bremen 41
Falls Church 41
Montreal 36
Toronto 36
Buffalo 35
Dearborn 34
Phoenix 34
Brooklyn 32
Tianjin 32
Atlanta 31
Denver 29
Hebei 28
Shenyang 27
The Dalles 27
Brussels 26
Changsha 25
Frankfurt am Main 25
Haiphong 25
Johannesburg 25
Hefei 23
Jiaxing 23
Addison 21
Amsterdam 21
Rome 21
Da Nang 20
Poplar 20
Stockholm 20
Ankara 19
Boston 19
Jinan 19
Rio de Janeiro 19
Bologna 18
Falkenstein 18
Manchester 18
Mountain View 18
Nuremberg 18
San Francisco 18
Chennai 17
Hangzhou 17
Timisoara 17
Vienna 17
Baghdad 16
Washington 16
Columbus 15
Moscow 15
Guangzhou 14
Norwalk 14
Philadelphia 14
Tashkent 14
Dong Ket 13
Kunming 13
Naples 13
Hải Dương 12
Belo Horizonte 11
Curitiba 11
Mumbai 11
Ningbo 11
Querétaro 11
Totale 13.242
Nome #
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 376
Absolute quantification of cell-free microRNAs in cancer patients 341
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 332
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 322
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 311
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 304
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 298
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 284
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 278
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 271
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 253
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 250
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 249
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 244
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 242
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 241
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 240
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 240
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 235
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines 233
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 233
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 228
A microRNA signature of hypoxia 226
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 224
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 220
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 217
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 212
Espressione dei MicroRNA nei carcinomi mammari 207
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice 203
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 201
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 200
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 199
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 199
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 199
Extensive modulation of a set of microRNAs in primary glioblastoma 195
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 195
Mutated beta-catenin evades a microRNA-dependent regulatory loop 194
Tumor suppressor functions of ARLTS1 in lung cancers 193
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 189
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 188
MicroRNA deregulation in human thyroid papillary carcinomas 187
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 183
Modulation of mismatch repair and genomic stability by miR-155 181
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 180
The Role of Micro-RNAs in Rheumatic Diseases: An Update 177
MicroRNAs in cancer (an overview) 177
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 177
Oncogenic role of miR-483-3p at the IGF2/483 locus 176
Micro-RNA profiling in kidney and bladder cancers 175
A microRNA expression signature of human solid tumors defines cancer gene targets 175
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 174
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 174
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 172
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 172
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 172
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 168
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells 167
Hemostasis gene expression of the internal jugular and saphenous veins 163
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 161
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome 161
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 161
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 161
Regulation of microRNA expression: the hypoxic component 160
Principles of MicroRNA involvement in breast cancer 157
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells 156
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 156
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 150
MicroRNAs and Their Role in Cancer 150
Micro-markers: microRNAs in cancer diagnosis and prognosis 149
MiR-15a and miR-16-1 cluster functions in human leukemia 149
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy 145
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 144
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. 143
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 142
OncomiR detection in circulating body fluids: A PDMS microdevice perspective 140
First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) 137
MicroRNAs as biomarker of Parkinson disease? Small but mighty. 137
MicroRNA coinvolti nello sviluppo del carcinoma epatocellulare. Identificazione delle proteine bersaglio. 134
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 134
MicroRNAs: toward the clinic for breast cancer patients 131
MicroRNA gene expression deregulation in human breast cancer 128
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 123
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 123
Involvement of the Inconstant Bursa of the Fifth Metatarsophalangeal Joint in Psoriatic Arthritis: A Clinical and Ultrasonographic Study 119
Karyotype-specific microRNA signature in chronic lymphocytic leukemia 119
Familial cancer associated with a polymorphism in ARLTS1 116
The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile 114
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas 114
null 111
Progetto triennale AIRC (MFAG 2011). Titolo: Circulating microRNAs as cancer-specific biomarkers 103
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review 102
null 101
null 96
null 94
null 94
null 93
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. 92
null 91
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 89
null 89
Totale 18.185
Categoria #
all - tutte 83.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.714
Totale 86.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.030 0 0 107 31 56 74 78 57 39 84 113 391
2022/20231.051 114 77 35 156 161 166 40 76 121 12 47 46
2023/2024561 70 63 23 8 43 111 27 35 10 22 9 140
2024/20252.571 43 46 181 121 316 251 118 143 482 238 362 270
2025/20266.591 673 211 522 842 887 417 869 413 680 607 325 145
2026/2027693 184 360 149 0 0 0 0 0 0 0 0 0
Totale 19.299